Owners, management and financials
CVR: 33242840
DKK 61,634,124
Gross profit
Net result: DKK 3,053,580
ICON CLINICAL (UK) LIMITED (100%)
CVR · view owners
Thomas Noel O´Leary
Board: Thomas Noel O´Leary (chair) and 2 members
CVR · view management
Active
Founded 7 October 2010
CVR · view overview
29 employees
CVR · 2018
Director role ended: Robert James Leftwich
CVR · 15/12/2023
View the full event history
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Thomas Noel O´Leary. The board consists of Thomas Noel O´Leary (chair), John Sheahan and Simon Peter Hollywood. The company is owned by ICON CLINICAL (UK) LIMITED. The company has 29 employees (2018). In 2025, the company reported a gross profit of DKK 61,634,124 and a net result of DKK 3,053,580 compared with DKK 3,554,282 the year before. Equity in the 2025 report amounted to DKK 23,945,884.
Source: annual report 2025, Danish Business Authority
The financial health of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS appears stable, with consistent gross profit and profit figures over the past few years. Gross profit has shown a positive trend, increasing from 44.7 million DKK in 2021 to 72.3 million DKK in 2024, while profit has also risen from 2.99 million DKK to 3.55 million DKK in the same period. The company's equity has grown significantly, reaching nearly 24 million DKK in 2025, indicating a strong financial foundation. However, the absence of disclosed revenue figures raises concerns about transparency and overall market position within the research and experimental development sector. Overall, the company demonstrates solid profitability and growth potential, though its lack of revenue data may limit its competitive visibility.
AI-generated summary · Generated 15/08/2026
Selskabets formål er at udføre generel klinisk forskning og hermed forbundet virksomhed efter bestyrelsens skøn.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 61.6 mio. | 3.1 mio. | 47.3 mio. | 23.9 mio. | 58 | |
| 202401/01/2024 – 31/12/2024 | 72.3 mio. | 3.6 mio. | 46.6 mio. | 20.9 mio. | 72 | |
| 202301/01/2023 – 31/12/2023 | 64 mio. | 3.1 mio. | 39 mio. | 17.3 mio. | 63 | |
| 202201/01/2022 – 31/12/2022 | 57.1 mio. | 2.7 mio. | 18.4 mio. | 14.2 mio. | 57 | |
| 202101/01/2021 – 31/12/2021 | 44.7 mio. | 3 mio. | 17.6 mio. | 11.5 mio. | 47 | |
| 202001/01/2020 – 31/12/2020 | 34.7 mio. | 2.1 mio. | 14 mio. | 8.5 mio. | 37 | |
| 201901/01/2019 – 31/12/2019 | 27 mio. | 1.6 mio. | 10.1 mio. | 6.4 mio. | 34 | |
| 201801/01/2018 – 31/12/2018 | 27.8 mio. | 1.4 mio. | 10.3 mio. | 4.9 mio. | 29 | |
| 201701/01/2017 – 31/12/2017 | 25.8 mio. | 1 mio. | 7.7 mio. | 3.5 mio. | 32 | |
| 201601/01/2016 – 31/12/2016 | 23.6 mio. | 1.2 mio. | 6.4 mio. | 2.5 mio. | - | |
| 201501/01/2015 – 31/12/2015 | 9.6 mio. | 459 t. | 5.5 mio. | 1.3 mio. | - | |
| 201401/01/2014 – 31/12/2014 | 4.8 mio. | 299 t. | 1.8 mio. | 845 t. | - | |
| 201301/01/2013 – 31/12/2013 | 3.8 mio. | 238 t. | 1.3 mio. | 546 t. | - | |
| 201201/01/2012 – 31/12/2012 | 2.2 mio. | 145 t. | 724 t. | 308 t. | - |
Compared to 1.039 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorThe CVR number of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS is 33242840.
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS is owned by ICON CLINICAL (UK) LIMITED.
The management of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS consists of Thomas Noel O´Leary.
The board of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS consists of Thomas Noel O´Leary, John Sheahan and Simon Peter Hollywood, with Thomas Noel O´Leary as chair.
In 2025, PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS reported a gross profit of DKK 61,634,124.
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS had 29 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Address changed to Strandvejen 102B 5. tv, 2900 Hellerup (September 17, 2026).
Contact info changed: new email: [email protected] (September 17, 2026).
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2025. Gross profit came to DKK 61,634,124, and the net result was DKK 3,053,580.
Address changed to H.C. Andersens Boulevard 48 1. 48, 1, 1553 København V (December 29, 2025).
As of August 14, 2025, BDO Statsautoriseret Revisionspartnerselskab has been appointed auditor of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
As of August 14, 2025, A/S PSE 17 NR. 1056 has stepped down as auditor of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2024. Gross profit came to DKK 72,283,676, and the net result was DKK 3,554,282.
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2023. Gross profit came to DKK 64,001,724, and the net result was DKK 3,114,123.
As of December 15, 2023, Thomas Noel O´Leary has joined the board of directors of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
As of December 15, 2023, Robert James Leftwich has left the board of directors of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
As of December 15, 2023, Thomas Noel O´Leary is registered as director of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
As of December 15, 2023, Robert James Leftwich has stepped down as director of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2022. Gross profit came to DKK 57,089,579, and the net result was DKK 2,723,224.
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2021. Gross profit came to DKK 44,685,539, and the net result was DKK 2,999,646.
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2020. Gross profit came to DKK 34,745,603, and the net result was DKK 2,056,895.
As of July 1, 2021, Simon Peter Hollywood has joined the board of directors of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
As of July 1, 2021, John Sheahan has joined the board of directors of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
As of July 1, 2021, Colin Shannon has left the board of directors of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
As of July 1, 2021, Christopher John Gray has left the board of directors of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
As of July 1, 2021, Robert James Leftwich is registered as director of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
As of July 1, 2021, Colin Shannon has stepped down as director of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2019. Gross profit came to DKK 26,958,407, and the net result was DKK 1,584,074.
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2018. Gross profit came to DKK 27,832,693, and the net result was DKK 1,376,133.
As of October 4, 2018, Robert James Leftwich has joined the board of directors of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
As of October 4, 2018, Timothy Jon McClain has left the board of directors of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2017. Gross profit came to DKK 25,838,522, and the net result was DKK 1,016,623.
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2016. Gross profit came to DKK 23,570,140, and the net result was DKK 1,162,789.
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2015. Gross profit came to DKK 9,625,172, and the net result was DKK 459,045.
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2014. Gross profit came to DKK 4,835,014, and the net result was DKK 299,046.
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2013. Gross profit came to DKK 3,833,252, and the net result was DKK 238,375.
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2012. Gross profit came to DKK 2,188,044, and the net result was DKK 145,112.
As of October 12, 2011, Timothy Jon McClain has joined the board of directors of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
As of October 12, 2011, Susan Caroline Stansfield has left the board of directors of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
As of October 7, 2010, A/S PSE 17 NR. 1056 has been appointed auditor of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
As of October 7, 2010, Colin Shannon has joined the board of directors of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
As of October 7, 2010, Christopher John Gray has joined the board of directors of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
As of October 7, 2010, Susan Caroline Stansfield has joined the board of directors of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
As of October 7, 2010, Colin Shannon is registered as director of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.
As of October 7, 2010, is registered as an owner of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS with an ownership share of 100%.
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS was founded on October 7, 2010.
Companies in the same industry and area
CVR 26392861
CVR 41366044
CVR 32971024
CVR 27701396
CVR 43932489
